Peter Greenleaf

Chief Executive Officer at Aurinia Pharmaceuticals · 6 reported transactions in 2 companies · latest trade Oct 2, 2026

Their trades


Pelthos TherapeuticsPTHS	Sold $16.9K · 797 shares	Oct 2, 2026	S&P 500 −1.8%thru Oct 30

Oct 2, 2026 · PTHS

$16.9K

S&P 500 −1.8%thru Oct 30

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Executive Officer at Aurinia Pharmaceuticals · 6 reported transactions in 2 companies · latest trade Oct 2, 2026


Pelthos TherapeuticsPTHS	Sold $16.9K · 797 shares	Oct 2, 2026	S&P 500 −1.8%thru Oct 30

Oct 2, 2026 · PTHS

$16.9K

S&P 500 −1.8%thru Oct 30

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.